NYSE:AZNAstraZeneca Stock Price, Forecast & News

AstraZeneca's stock was trading at $44.58 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, AZN stock has increased by 20.7% and is now trading at $53.80. View which stocks have been most impacted by Coronavirus.

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AstraZeneca in the last year. There are currently 4 sell ratings, 2 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for AstraZeneca.

AstraZeneca is scheduled to release its next quarterly earnings announcement on Thursday, July 30th 2020. View our earnings forecast for AstraZeneca.

AstraZeneca plc (NYSE:AZN) released its quarterly earnings data on Wednesday, April, 29th. The company reported $0.53 EPS for the quarter, topping the consensus estimate of $0.47 by $0.06. The firm earned $6.35 billion during the quarter, compared to the consensus estimate of $5.95 billion. AstraZeneca had a net margin of 5.94% and a return on equity of 33.97%. The firm's revenue was up 16.3% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.89 earnings per share. View AstraZeneca's earnings history.

AstraZeneca declared a semi-annual dividend on Tuesday, February 18th. Investors of record on Friday, February 28th will be paid a dividend of $0.95 per share on Monday, March 30th. This represents a dividend yield of 2.8%. The ex-dividend date of this dividend is Thursday, February 27th. View AstraZeneca's dividend history.

Shares of AstraZeneca split on Monday, July 27th 2015. The 2-1 split was announced on Friday, June 26th 2015. The newly issued shares were payable to shareholders after the closing bell on Friday, July 24th 2015. An investor that had 100 shares of AstraZeneca stock prior to the split would have 200 shares after the split.

11 brokerages have issued twelve-month price targets for AstraZeneca's shares. Their forecasts range from $60.00 to $65.00. On average, they anticipate AstraZeneca's share price to reach $61.67 in the next twelve months. This suggests a possible upside of 14.6% from the stock's current price. View analysts' price targets for AstraZeneca.

News headlines about AZN stock have trended negative on Sunday, InfoTrie reports. The research group scores the sentiment of press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. AstraZeneca earned a media sentiment score of -2.2 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 5.0 out of 10, indicating that recent press coverage is somewhat likely to have an effect on the stock's share price in the next few days. View the latest news about AstraZeneca.

Some companies that are related to AstraZeneca include Johnson & Johnson (JNJ), Roche Holdings AG Basel (RHHBY), Novartis (NVS), Merck & Co., Inc. (MRK), Pfizer (PFE), Abbott Laboratories (ABT), Eli Lilly And Co (LLY), Novo Nordisk A/S (NVO), AbbVie (ABBV), Bristol-Myers Squibb (BMY), Sanofi (SNY), GlaxoSmithKline (GSK), Commonwealth Bank of Australia (CSLLY), Celgene (CELG) and Vertex Pharmaceuticals (VRTX). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other AstraZeneca investors own include Pfizer (PFE), AbbVie (ABBV), AT&T (T), Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), NVIDIA (NVDA), Alibaba Group (BABA), Cisco Systems (CSCO), Bank of America (BAC) and Johnson & Johnson (JNJ).

AstraZeneca trades on the New York Stock Exchange (NYSE) under the ticker symbol "AZN."

AstraZeneca's stock is owned by a variety of institutional and retail investors. Top institutional investors include Park National Corp OH (0.01%) and First Financial Bank Trust Division (0.00%). View institutional ownership trends for AstraZeneca.

AZN stock was sold by a variety of institutional investors in the last quarter, including Park National Corp OH. View insider buying and selling activity for AstraZeneca.

AZN stock was acquired by a variety of institutional investors in the last quarter, including First Financial Bank Trust Division. View insider buying and selling activity for AstraZeneca.

Shares of AZN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of AZN stock can currently be purchased for approximately $53.80.

AstraZeneca has a market capitalization of $141.19 billion and generates $24.38 billion in revenue each year. The company earns $1.34 billion in net income (profit) each year or $1.75 on an earnings per share basis. AstraZeneca employs 64,400 workers across the globe.

The official website for AstraZeneca is www.astrazeneca.com.

AstraZeneca's mailing address is 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS, CAMBRIDGE X0, CB2 0AA. The company can be reached via phone at 44-20-3749-5000 or via email at [email protected]